Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Kidney Transplant I: Introduction

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Author Correction: Physiology and immunology of a pig-to-human decedent kidney xenotransplant.

Nature·2026

Same author

Kidney Transplantation in Two Highly Sensitized Candidates after CAR T-Cell Therapy.

The New England journal of medicine·2026

Same author

Bridging monitoring gaps in global drylands with big data and collaboration.

npj biodiversity·2026

Same author

Contemporary Trends in Heart Failure Mortality: The Pandemic Ended, the Epidemic Continues.

JACC. Heart failure·2026

Same author

"Leave a Little Ray of Hope": Perspectives From Providers, Patients, and Caregivers on Palliative Care and Future Health Care Planning for Patients Ineligible for Kidney Transplantation.

Kidney medicine·2026

Same author

Inhibition of NFAT after human uterus transplant promotes loss of tissue-resident NK cells and attendant pregnancy complications.

Science translational medicine·2026

Search research articles

Related Experiment Video

Updated: Jul 8, 2026

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

ABO-incompatible transplantation: less may be more.

Robert A Montgomery¹, Jayme E Locke

¹Department of Surgery, Johns Hopkins University, Baltimore, MD, USA. rmonty@jhmi.edu.us

Transplantation

|January 25, 2008

Summary

This summary is machine-generated.

ABO-incompatible kidney transplants can be safely performed with plasmapheresis and immunoglobulin, avoiding risky B-cell ablative therapies. This approach expands the donor pool, offering functional kidneys with minimal rejection and lower costs than dialysis.

More Related Videos

Planarian Immobilization, Partial Irradiation, and Tissue Transplantation

Planarian Immobilization, Partial Irradiation, and Tissue Transplantation

Published on: August 6, 2012

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

Related Experiment Videos

Last Updated: Jul 8, 2026

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

Planarian Immobilization, Partial Irradiation, and Tissue Transplantation

Planarian Immobilization, Partial Irradiation, and Tissue Transplantation

Published on: August 6, 2012

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

Area of Science:

Nephrology
Transplantation Immunology

Background:

ABO-incompatible kidney transplantation is crucial for expanding the donor pool.
Traditional B-cell ablative therapies (e.g., anti-CD20, splenectomy) increase infection risk.

Purpose of the Study:

To evaluate a modified protocol for ABO-incompatible kidney transplantation using plasmapheresis and low-dose intravenous immunoglobulin.
To assess the safety and efficacy of this approach in preventing antibody-mediated rejection and graft loss.

Main Methods:

A cohort of 53 patients underwent ABO-incompatible kidney transplantation.
The protocol included plasmapheresis preconditioning, low-dose intravenous immunoglobulin, and standard maintenance immunosuppression.
Patients were followed for a mean of 2 years.

Main Results:

The protocol demonstrated a low risk of antibody-mediated rejection and graft loss.
Mean creatinine clearance at 1 and 3 years was 58 mL/min and 63 mL/min, respectively, indicating good long-term function.
Prompt graft function was observed with minimal early loss.

Conclusions:

ABO-incompatible kidney transplantation can be safely achieved with a modified immunosuppression strategy, expanding donor options.
This approach offers a viable alternative to dialysis with potentially lower healthcare costs.
Long-term follow-up is necessary, but initial results suggest excellent graft survival and function.